Inventor · disambiguated record
Mark E. Scott
Also filed as: SCOTT MARK · SCOTT MARK E
19 granted patents·1 pending application·34 citations·filing 2010–2022
91Inventor score
Files withMERCK SHARP & DOHME12GILEAD SCIENCES INC3BARR KENNETH JAY1EDMONDSON SCOTT D1FLARE THERAPEUTICS INC1
Top patents by PatentIndex Score
20 records- 0191US10487090B2Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereofGILEAD APOLLO LLC·Filed 2018·Granted Nov 26, 2019·7 cites·3 claims
- 0287US9580407B2Regioselective N-2 arylation of indazolesMERCK SHARP & DOHME·Filed 2013·Granted Feb 28, 2017·5 cites·25 claims
- 0385US10815214B2Regioselective N-2 arylation of indazolesMERCK SHARP & DOHME·Filed 2019·Granted Oct 27, 2020·2 cites·8 claims
- 0485US10745412B2Processes for preparing ACC inhibitors and solid forms thereofGILEAD SCIENCES INC·Filed 2019·Granted Aug 18, 2020·2 cites·2 claims
- 0585US10287272B2Substituted indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted May 14, 2019·3 cites·30 claims
- 0683US10435386B2Regioselective N-2 arylation of indazolesMERCK SHARP & DOHME·Filed 2017·Granted Oct 8, 2019·2 cites·2 claims
- 0779US8993756B2Pyrrolopyrimidines as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Mar 31, 2015·6 cites·3 claims
- 0878US10519165B2Processes for preparing ACC inhibitors and solid forms thereofGILEAD SCIENCES INC·Filed 2018·Granted Dec 31, 2019·3 cites·4 claims
- 0971US10344000B2Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted Jul 9, 2019·1 cites·23 claims
- 1071US9725445B2Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 8, 2017·2 cites·17 claims
- 1169US11279710B2Processes for preparing ACC inhibitors and solid forms thereofGILEAD SCIENCES INC·Filed 2020·Granted Mar 22, 2022·0 cites·3 claims
- 1267US10689369B2Substituted indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2019·Granted Jun 23, 2020·0 cites·24 claims
- 1366US9957264B2Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·1 cites·9 claims
- 1453US2025122169A1Pparg inverse agonists and uses thereofFLARE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1543US10059705B2Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 28, 2018·0 cites·7 claims
- 1643US9957265B2N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·0 cites·11 claims
- 1739US10072025B2Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Sep 11, 2018·0 cites·17 claims
- 1837US9486448B2Pyrrolidine derived beta 3 adrenergic receptor agonistsBARR KENNETH JAY·Filed 2014·Granted Nov 8, 2016·0 cites·14 claims
- 1937US8937077B2Bicyclic diamines as janus kinase inhibitorsGUERIN DAVID JOSEPH·Filed 2011·Granted Jan 20, 2015·0 cites·14 claims
- 2033US8604038B2Pyrrolidine derived beta 3 adrenergic receptor agonistsEDMONDSON SCOTT D·Filed 2010·Granted Dec 10, 2013·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Mark E. Scott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →